25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy

Kidney International

Volumn 68, Issue 4, 2005, Pages 1840-1848

  Coen, Giorgio ^a   Mantella, Daniela ^b   Manni, Micaela ^b   Balducci, Alessandro ^b   Nofroni, Italo ^b   Sardella, Daniela ^b   Ballanti, Paola ^b   Bonucci, Ermanno ^b  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b NONE

Author keywords

25 OH vitamin D; Bone biopsy; Bone turnover; Chronic renal failure; Hemodialysis; Osteomalacia; Renal osteodystrophy; Secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM SALT; ERYTHROPOIETIN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; TETRACYCLINE;

ADULT; AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE BIOPSY; BONE MINERALIZATION; BONE TURNOVER; CHEMICAL LABELING; CHRONIC GLOMERULONEPHRITIS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPOTHESIS; ILIAC BONE; INTERSTITIAL NEPHRITIS; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; KIDNEY POLYCYSTIC DISEASE; MALE; METABOLITE; MOLECULAR DYNAMICS; NEPHROLITHIASIS; OBSERVATION; OSSIFICATION; OSTEOBLAST; OSTEOMETRY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; STANDARD; SURFACE PROPERTY; TRABECULAR BONE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; BIOPSY; BONE AND BONES; CALCITRIOL; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 31644439542     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00603.x     Document Type: Article

References (28)

1. SCHARLA SH: Prevalence of subclinical vitamin D deficiency in different european countries. Osteoporosis Int 8 (Suppl 2):S7-S12, 1998
2. LIPS P, DUONG T, OLEKSIK A, et al: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrinol Metab 86:1212-1221, 2001
3. SOUBERBIELLE JC, CORMIER C, KINDERMANS C, et al: Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86:3086-3090, 2001
4. SHERMAN SS, HOLLIS BW, TOBIN JD: Vitamin D status andrelated parameters in a healthy population: The effect of age, sex and season. J Clin Endocrinol Metab 71:405-413, 1990
5. GOMEZ-ALONSO C, NAVES-DIAZ ML, FERNANDEZ-MARTIN JL, et al: Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 63 (Suppl 85):S544-S548, 2003
6. OFFERMAN G, SCHAEFER K, SCHULZ A, DELLING G: Immunoreaktives parathormon, 25-hydroxycalciferol und Knochenhistologie bei renaler Osteopenie. Klin Wschr 54: 625-632, 1976
7. COEN G, MANTELLA D, CALABRIA S, et al: Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure. Am J Nephrol 20:283-290, 2000
8. EASTWOOD JB, HARRIS E, STAMP TCB, DE WARDENER HE: Vitamin D deficiency in the osteomalacia of chornic renal failure. Lancet 2:1209-1211, 1976
9. GHAZALI A, FARDELLONE P, PRUNA A, et al: Is low plasma 25(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55:2169-2177, 1999
10. SATO Y, ASOH T, KONDO I, SATOH K: Vitamin D deficiency and risk of hip fractures among disables elderly stroke patients. Stroke 32:1673-1677, 2001
11. PARFITT AM, GALLAGHER JC, HEANEY RP, et al: Vitamin D and bone health in the elderly. Am J Clin Nutr 36:1014-1031, 1982
12. ALEM AM, SHERRARD DJ, GILLEN DL, et al: Increased risk of hip fractures among patients with end-stage renal disease. Kidney Int 58:396-399, 2000
13. COCO M, RUSH H: Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115-11521, 2000
14. COEN G, BALLANTI P, BONUCCI E, et al: Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13:2294-2302, 1998
15. MALONEY NAQ, OTT SM, ALFREY AC. et al: Histological quantification of aluminium in iliac bone from patients with renal failure. J Lab Clin Med 99:206-216, 1982
16. PARFITT AM, DREZNER MK, GLORIEUX FH, et al: Bone histomorphometry standardization of nomenclature, symbols and units. Bone Miner 2:595-610, 1987
17. BALLANTI P, BONUCCI E, DELLA ROCCA C, et al: Bone histomorphometric reference values in 88 normal Italian subjects. Bone Miner 11:187-197, 1990
18. MALLUCHE HH, FAUGERE MC: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211, 1990
19. FOURNIER A, GHITU S, BAKO G, et al: (letter and reply): Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13:2772-2774, 1999
20. VIETH R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-856, 1999
21. MCKENNA MJ, FREANEY R: Secondary hyperparathyroidism in the elderly: Means to defining hypovitaminosis D. Osteoporosis Int 8 (Suppl 2):S3-S6, 1998
22. ISHIMURA E, NISHIZAWA, INABA M, et al: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxy vitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019-1027, 1999
23. 3. J Clin Endocrinol Metab 59: 1063-1069, 1984
24. QAW F, CALVERLEY MJ, SCHROEDER NJ, et al: In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha, 25- and 1 beta, 25-dihydrotachysterol metabolites and studies of their biological activity. J Biol Chem 268:282-292, 1993
25. DUSSO AS, FINCH J, BROWN J, et al: Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72:157-164, 1991
26. 3 on the formation and function of osteoclastic cells. Calcif Tissue Int 52:255-260, 1993
27. 3 prmotes bone formation without causing excessive resoprtion in hypophosphatemic mice. Endocrinology 137:2633-2637, 1996
28. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Sisease. Am J Kidney Dis 42 (Suppl 3): S1-S170, 2003